📣 VC round data is live. Check it out!

Tactile Medical Valuation Multiples

Discover Tactile Medical's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Bioventus, Polynovo, Sofwave Medical, NeuroPace and more.

Tactile Medical Overview

About Tactile Medical

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.


Founded

1995

HQ

United States

Employees

1.1K

Financials (LTM)

Revenue: $344M
EBITDA: $47M

EV

$476M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Tactile Medical Financials

Tactile Medical reported last 12-month revenue of $344M and EBITDA of $47M.

In the same LTM period, Tactile Medical generated $262M in gross profit, $47M in EBITDA, and $22M in net income.

Revenue (LTM)


Tactile Medical P&L

In the most recent fiscal year, Tactile Medical reported revenue of $330M and EBITDA of $45M.

Tactile Medical is profitable as of last fiscal year, with gross margin of 76%, EBITDA margin of 14%, and net margin of 6%.

See analyst estimates for Tactile Medical
LTMLast FY202320242025202620272028
Revenue$344M$330M$274M$293M$330M
Gross Profit$262M$250M$195M$217M$250M
Gross Margin76%76%71%74%76%
EBITDA$47M$45M$25M$32M$39M
EBITDA Margin14%14%9%11%12%
EBIT Margin9%9%7%8%9%
Net Profit$22M$19M$29M$17M$19M
Net Margin6%6%10%6%6%

Financial data powered by Morningstar, Inc.

Tactile Medical Stock Performance

Tactile Medical has current market cap of $551M, and enterprise value of $476M.

Market Cap Evolution


Tactile Medical's stock price is $24.41.

Tactile Medical share price decreased by 0.8% in the last 30 days, and increased by 140.7% in the last year.

Tactile Medical has an EPS (earnings per share) of $0.85.

See more trading valuation data for Tactile Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$476M$551M1.7%-0.8%-6.6%140.7%$0.85

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Tactile Medical Valuation Multiples

Tactile Medical trades at 1.4x EV/Revenue multiple, and 10.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Tactile Medical

EV / Revenue (LTM)


Tactile Medical Financial Valuation Multiples

As of June 3, 2026, Tactile Medical has market cap of $551M and EV of $476M.

Tactile Medical has a P/E ratio of 25.3x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.4x1.7x1.6x1.4x
EV/EBITDA10.1x10.6x19.4x14.7x12.2x
EV/EBIT15.4x16.2x26.4x21.4x16.2x
EV/Gross Profit1.8x1.9x2.4x2.2x1.9x
P/E25.3x28.8x19.3x32.5x28.8x
EV/FCF-11.8x14.3x12.5x11.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Tactile Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Tactile Medical Margins & Growth Rates

Tactile Medical grew revenue by 11% and EBITDA by 12% in the last fiscal year.

In the most recent fiscal year, Tactile Medical reported gross margin of 76%, EBITDA margin of 14%, and net margin of 6%.

See estimated margins and future growth rates for Tactile Medical

Tactile Medical Margins

Last FY202420252026202720282029
Gross Margin76%74%76%77%
EBITDA Margin14%11%12%14%
EBIT Margin9%8%9%9%
Net Margin6%6%6%7%
FCF Margin12%13%12%-

Tactile Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth11%7%12%11%
Gross Profit Growth12%11%15%12%
EBITDA Growth12%32%21%29%
EBIT Growth13%23%32%13%
Net Profit Growth33%(41%)13%33%
FCF Growth-14%6%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Tactile Medical Operational KPIs

Tactile Medical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Tactile Medical's Rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Tactile Medical's Rule of X is 41% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Tactile Medical
LTMLast FY202320242025202620272028
Rule of 4024%24%---
Bessemer Rule of X39%41%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue37%37%39%38%37%
G&A Expenses to Revenue27%27%23%24%27%
R&D Expenses to Revenue3%3%3%3%3%
Opex to Revenue-67%65%66%67%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Tactile Medical Competitors

Tactile Medical competitors include Bioventus, Polynovo, Sofwave Medical, NeuroPace, Cytek Biosciences, Cerus, Japan Lifeline, IBA Group, MiMedx Group and Beta Bionics.

Most Tactile Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Bioventus1.4x1.3x6.8x6.7x
Polynovo5.9x5.0x72.0x57.2x
Sofwave Medical6.0x-68.7x-
NeuroPace5.7x5.7x(114.3x)(86.6x)
Cytek Biosciences1.5x1.5x(463.4x)(186.0x)
Cerus2.4x2.3x58.8x40.6x
Japan Lifeline1.4x1.3x5.8x5.6x
IBA Group0.8x0.8x11.4x10.8x

This data is available for Pro users. Sign up to see all Tactile Medical competitors and their valuation data.

Start Free Trial

Acquisitions by Tactile Medical

Tactile Medical has acquired 2 companies to date.

Last acquisition by Tactile Medical was on February 17th 2026. Tactile Medical acquired LymphaTech for $7M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Tactile Medical

LymphaTech
AffloVest
Description
LymphaTech is an Atlanta-based healthcare technology firm offering 3D body scanning for early lymphedema detection and treatment monitoring, aiding breast cancer survivors and clinicians. Founded in 2014.
AffloVest is a wearable percussion therapy device designed for airway clearance in patients with chronic respiratory diseases. Nashville-based AffloVest employs high-frequency chest wall oscillation via a portable vest connected to a generator, treating conditions including COPD, cystic fibrosis, bronchiectasis, and neuromuscular disorders. Cleared by the FDA, it supports home and clinical use with customizable pressure settings and session durations up to 30 minutes.
HQ CountryUnited StatesUnited States
HQ City
-
Austin, TX
Deal Date17 Feb 20268 Sep 2021
Valuation$7M$100M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Tactile Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Tactile Medical

When was Tactile Medical founded?Tactile Medical was founded in 1995.
Where is Tactile Medical headquartered?Tactile Medical is headquartered in United States.
How many employees does Tactile Medical have?As of today, Tactile Medical has over 1K employees.
Who is the CEO of Tactile Medical?Tactile Medical's CEO is Sheri Louise Dodd.
Is Tactile Medical publicly listed?Yes, Tactile Medical is a public company listed on Nasdaq.
What is the stock symbol of Tactile Medical?Tactile Medical trades under TCMD ticker.
When did Tactile Medical go public?Tactile Medical went public in 2016.
Who are competitors of Tactile Medical?Tactile Medical main competitors include Bioventus, Polynovo, Sofwave Medical, NeuroPace, Cytek Biosciences, Cerus, Japan Lifeline, IBA Group, MiMedx Group, Beta Bionics.
What is the current market cap of Tactile Medical?Tactile Medical's current market cap is $551M.
What is the current revenue of Tactile Medical?Tactile Medical's last 12 months revenue is $344M.
What is the current revenue growth of Tactile Medical?Tactile Medical revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of Tactile Medical?Current revenue multiple of Tactile Medical is 1.4x.
What is the current EBITDA of Tactile Medical?Tactile Medical's last 12 months EBITDA is $47M.
What is Tactile Medical's EBITDA margin?Tactile Medical's last 12 months EBITDA margin is 14%.
What is the current EV/EBITDA multiple of Tactile Medical?Current EBITDA multiple of Tactile Medical is 10.1x.
How many companies Tactile Medical has acquired to date?As of June 2026, Tactile Medical has acquired 2 companies.
What was the largest acquisition by Tactile Medical?$100M acquisition of AffloVest on 8th September 2021 was the largest M&A Tactile Medical has done to date.
What companies Tactile Medical acquired?Tactile Medical acquired AffloVest and LymphaTech.
In how many companies Tactile Medical has invested to date?Tactile Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Tactile Medical

Lists including Tactile Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial